A Prospective Study of Clinical Factors Affecting Disease Progression and Treatment Results of Patients With Tumors of the Prostate Bladder and Kidney.

  • End date
    Aug 21, 2025
  • participants needed
  • sponsor
    Meir Medical Center
Updated on 21 January 2021
kidney cancer


Identifying clinical factors such as medication, background diseases and blood tests that effect the course of disease in cancer patients can help physicians to better decide on the patient's treatment plan. The study seeks to identify and analyze relevant clinical factors that effect the course of the disease and the results of treatment in patients with cancers of the prostate, bladder and kidney.

Condition Malignant neoplasm of prostate, Prostate Cancer, Prostate Cancer, Early, Recurrent, urinary tract neoplasm, Urologic Cancer, Malignant neoplasm of kidney, Kidney Cancer, Renal Cancer, Nephropathy, Nephropathy, Kidney Disease, Kidney Disease (Pediatric), Prostatic disorder, Prostate Disorders, bladder cancer, bladder cancer, Bladder Carcinoma, Urothelial Cancer, bladder disorder, Bladder Disorders, Prostate Disorders, Kidney Disease (Pediatric), Prostate Cancer, Early, Recurrent, Urothelial Cancer, Kidney Cancer, Prostate Cancer, Kidney Disease, Bladder Disorders, Renal Cancer, Bladder Carcinoma, Urologic Cancer, prostate carcinoma, carcinoma of the bladder, cancer, renal, prostate cancers, bladder tumor
Clinical Study IdentifierNCT02186925
SponsorMeir Medical Center
Last Modified on21 January 2021


Yes No Not Sure

Inclusion Criteria

All patients with prostate, bladder or kidney cancer that are being treated at the Meir Medical Center and are over 18 years of age

Exclusion Criteria

Patients under the age of 18
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact


Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note